Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001193125-26-410001

Chief Financial Officer bought 15,000 shares at $37.32 ($559,740)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelly Thomas Patrick Chief Financial Officer 2026-09-30 Purchase +15,000 $37.32 $559,740 15,000 D
Open-market purchases · 15,000 sh · avg $37.32 · $559,740
Loading xslF345X06/ownership.xml…